Seeking Alpha

Kevin CC

 
View as an RSS Feed
View Kevin CC's Articles BY TICKER:
  • Anacor Knocking On The Door
    Dec. 18, 2012 ANAC 11 Comments
  • Pfizer's Xeljanz Gets Approval, While Lilly's Baricitinib Looks Strong
    Nov. 21, 2012 PFE, LLY 8 Comments
  • Chelsea: Raising Funds While Stuck In The Muck
    Jul. 4, 2012 CHTP 22 Comments
  • Chelsea: A Short-Term Buying Opportunity
    May. 23, 2012 CHTP 21 Comments
  • Pfizer: Is 8 Really Enough?
    May. 11, 2012 PFE Comment!
  • Oral Rheumatoid Arthritis Market Remains Open As FDA Questions Efficacy Of Pfizer's Pill
    May. 9, 2012 PFE 4 Comments
  • Will Safety Issues Thwart Pfizer's Arthritis Convenience Play?
    Apr. 25, 2012 PFE 1 Comment
  • Chelsea Drops While Trying To Prevent Falls
    Apr. 10, 2012 CHTP 17 Comments